Advanced search×

Serum N-glycome biomarker for monitoring development of DENA-induced hepatocellular carcinoma in rat.

Mol Cancer (2010) PMID 20704698

There is a demand for serum markers for the routine assessment of the progression of liver cancer. We previously found that serum N-linked sugar chains are altered in hepatocellular carcinoma (HCC). Here, we studied glycomic alterations during development of HCC in a rat model.

DOI: 10.1186/1476-4598-9-215
Version: za2963e q8zad q8zbb q8zc1 q8zde q8ze5 q8zfc q8zg9

Similar articles you may find interesting…

  1. Alteration of N-glycome in diethylnitrosamine-induced hepatocellular carcinoma mice: a non-invasive monitoring tool for liver cancer.

    Liver Int 30(8):1221-8 (2010) PMID 20524982

    The changes of N-glycan levels in the serum could be used as a biomarker to monitor the progress of HCC and to follow up the treatment of liver tumours in this DENA mouse model....
  2. Altered serum glycomics in Alzheimer disease: a potential blood biomarker?

    Rejuvenation Res 13(4):439-44 (2010) PMID 20426627

  3. Conservative and operative management of benign solid hepatic tumours: a successful stratified algorithm.

    Audio, Transactions of the IRE Professi... 22(11):1337-44 (2010) PMID 20683192

    I and 87 months in group II, no misdiagnosis or evolution towards malignancy was encountered. Interestingly, 87.9% of all observed benign liver tumours remained stable, decreased in size or disappeared. None of the remaining lesions required surgery. A restrictive policy of surgical management of be...